| Efficacy of Low Dose Naltrexone in Psoriasis (NCT04250792) | Jinnah Postgraduate Medical Centre | 2019-01-01 |
| Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered With HIV DNA CON-S Env Vaccine in Healthy, HIV-1-Uninfected Adults (NCT03505060) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-01-01 |
| Antepartum Etonogestrel Contraceptive Implant Insertion at Term (NCT03656289) | University of Colorado, Denver | 2019-01-01 |
| Effect of Lidocaine Phonophoresis Versus Pulsed Ultrasound on Myofascial Pain Syndrome in Athletic Children (NCT04185194) | Cairo University | 2019-01-01 |
| Tisagenlecleucel In Primary CNS Lymphoma (NCT04134117) | Matthew J. Frigault, M.D. | 2019-01-01 |
| Minocycline Treatment for Cystoid Macular Edema (NCT05474950) | Sun Yat-sen University | 2019-01-01 |
| Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma (NCT03631836) | Assistance Publique Hopitaux De Marseille | 2019-01-01 |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer (NCT03797443) | Piedmont Cancer Institute | 2019-01-01 |
| Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia (NCT03902925) | University of Sao Paulo | 2019-01-01 |
| Effects of Restylane-L® Filler Injection for Non-Surgical Rhinoplasty (NCT04169308) | DeNova Research | 2019-01-01 |
| Combination of Hypofractionated Proton Therapy With Immunotherapy (NCT03764787) | Peking University First Hospital | 2019-01-01 |
| Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor (NCT03518268) | Tel-Aviv Sourasky Medical Center | 2019-01-01 |
| A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites (NCT03736122) | BioSyngen Pte Ltd | 2019-01-01 |
| Lenalidomide, Rituximab, Gemcitabine, Oxaliplatin and Dexamethasone in Relapse and Refractory DLBCL (NCT03795571) | The First Affiliated Hospital with Nanjing Medical University | 2019-01-01 |
| Management of Malignant Pleural Effusion With Indwelling Pleural Catheter Versus Silver Nitrate Pleurodesis (NCT03781908) | Assiut University | 2019-01-01 |
| Project CORE: Disseminating Eating Disorders Treatment (NCT03855553) | The Miriam Hospital | 2019-01-01 |
| A Study of Fibrin Sealant Plus Silver Microparticles to Prevent Incisional Hernias Following Abdominal Surgery (NCT02584153) | Hobart Harris | 2019-01-01 |
| Potential Injection of Human Umbilical Cord Secretome in the Case of Trophic Ulcers (Pre-post Intervention) (NCT05777213) | Yohanes Firmansyah, dr, MH, MM | 2019-01-01 |
| Multimodal and Unimodal Analgesia in Cholecystectomy (NCT05547659) | October 6 University | 2019-01-01 |
| Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia (NCT04094207) | Sadat City University | 2019-01-01 |
| Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury (NCT02323698) | Spaulding Rehabilitation Hospital | 2019-01-01 |
| Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia (NCT03718234) | University of Minnesota | 2019-01-01 |
| Dexmedetomidine Versus Fentanyl Added to Levobupivacaine for Transversus Abdominis Plane (TAP) Block (NCT03778671) | Assiut University | 2019-01-01 |
| Clinical Evaluation of Bioactive Resin Sealants vs Conventional Sealants in Permanent Molars (NCT03779893) | Cairo University | 2019-01-01 |
| Combination of Proton Therapy With Immunotherapy in Multiple Metastases Cancer (NCT03765190) | Peking University First Hospital | 2019-01-01 |
| Grape Seeds Versus Standard Measures for Prevention of Caries Incidence (NCT03724578) | Cairo University | 2019-01-01 |
| AIN Transfer for Cubital Tunnel Syndrome (NCT05242302) | University of Alberta | 2019-01-01 |
| Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab (NCT03709706) | GlaxoSmithKline | 2018-12-31 |
| Isometric Intervention for Lateral Elbow Tendinopathy (NCT03756155) | University of Minnesota | 2018-12-31 |
| A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors (NCT03792750) | Bristol-Myers Squibb | 2018-12-31 |
| Evaluating Predictive Methods & Product Performance in Healthy Adults for Pediatric Patients, A Case Study: Furosemide (NCT03093090) | Yale University | 2018-12-31 |
| Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant (NCT03531281) | City of Hope Medical Center | 2018-12-30 |
| Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma (NCT03782415) | MediciNova | 2018-12-29 |
| Ketamine for Major Depressive Disorder (NCT03721900) | Shenox Pharmaceuticals, LLC | 2018-12-28 |
| The Absorption, Metabolism and Excretion of [14C]Ensartinib in Human (NCT03804541) | Betta Pharmaceuticals Co., Ltd. | 2018-12-28 |
| Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC (NCT03616886) | Jules Bordet Institute | 2018-12-28 |
| Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment (NCT04287894) | The Netherlands Cancer Institute | 2018-12-28 |
| A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Asian Patients With Advanced Cancer (NCT03808870) | NatureWise Biotech & Medicals Corporation | 2018-12-28 |
| Study of Safety and Tolerability of DCR HBVS (NCT03772249) | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 2018-12-28 |
| A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects (NCT03844906) | Supernus Pharmaceuticals, Inc. | 2018-12-27 |
| A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC (NCT03819465) | AstraZeneca | 2018-12-27 |
| Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE (NCT03635450) | Joanne Kurtzberg, MD | 2018-12-27 |
| Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia (NCT03826992) | Children's Hospital Medical Center, Cincinnati | 2018-12-27 |
| Study to Determine Safety and Dose of NJH395 in Non-breast HER2+ Advanced Cancer (NCT03696771) | Novartis Pharmaceuticals | 2018-12-27 |
| Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors (NCT03604783) | Sumitomo Pharma America, Inc. | 2018-12-26 |
| Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia (NCT03796390) | Hebei Senlang Biotechnology Inc., Ltd. | 2018-12-26 |
| Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO (NCT03790852) | Kodiak Sciences Inc | 2018-12-26 |
| In Vivo Performance of Oral Liquid Formulations of Budesonide in the Fasted State in Healthy Subjects (NCT05429775) | Sandoz | 2018-12-26 |
| Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer (NCT03559049) | University of Michigan Rogel Cancer Center | 2018-12-24 |
| A Multiple Dose of HL237 in Healthy Male Subject (NCT03896594) | Hanlim Pharm. Co., Ltd. | 2018-12-24 |
| Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer (NCT03477864) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2018-12-24 |
| Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma (NCT03523975) | City of Hope Medical Center | 2018-12-24 |
| Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 (NCT03618758) | Seoul National University Bundang Hospital | 2018-12-24 |
| Immunogenicity and Safety Study of NBP615 in Healthy Female (NCT04453241) | SK Bioscience Co., Ltd. | 2018-12-22 |
| rCSP/AP10-602 [GLA-LSQ] Vaccine Trial (NCT03589794) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-12-21 |
| Trial of Surufatinib Combined With JS001 in the Treatment of Advanced Solid Tumors (NCT03879057) | Peking University | 2018-12-21 |
| Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors (NCT03700294) | ADC Therapeutics S.A. | 2018-12-21 |
| Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection. (NCT03697226) | Antiva Biosciences | 2018-12-21 |
| Anlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLC (NCT03726736) | Yong Fang | 2018-12-21 |
| A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer (NCT03742102) | AstraZeneca | 2018-12-21 |
| A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects. (NCT04322266) | Hanmi Pharmaceutical Company Limited | 2018-12-21 |
| Study of CPI-100 in Patients With Advanced Tumors (NCT03781362) | Coordination Pharmaceuticals, Inc. | 2018-12-21 |
| Renal Anhydramnios Fetal Therapy (NCT03101891) | Johns Hopkins University | 2018-12-21 |
| Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency (NCT03601286) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2018-12-21 |
| Evaluate the Safety and Tolerability, as Well as the Pharmacokinetic and Pharmacodynamic Profiles of Single and Multiple Doses of Eplontersen Administered Subcutaneously to Healthy Volunteers and Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR ). (NCT03728634) | Ionis Pharmaceuticals, Inc. | 2018-12-21 |
| Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients (NCT03866577) | Momenta Pharmaceuticals, Inc. | 2018-12-21 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single Ascending Doses of CC-92480 in Healthy Subjects (NCT03803644) | Celgene | 2018-12-21 |
| A Safety and PK Study of IV Eravacycline (NCT03696550) | Tetraphase Pharmaceuticals, Inc | 2018-12-20 |
| A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy Participants (NCT03808259) | Janssen Research & Development, LLC | 2018-12-20 |
| Effect of Food on Pharmacokinetics of Salvianolic Acid A in Healthy Subjects (NCT03791463) | Peking University First Hospital | 2018-12-20 |
| A Study to Evaluate Safety, Tolerability, and Distribution of a Microdose of Radiolabeled BIIB067 (99mTc-MAG3-BIIB067) Co-administered With BIIB067 (Tofersen) to Healthy Adults (NCT03764488) | Biogen | 2018-12-20 |
| Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type (NCT03714958) | Centre Leon Berard | 2018-12-20 |
| Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer (NCT03724851) | MedPacto, Inc. | 2018-12-20 |
| A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors (NCT03811652) | MedImmune LLC | 2018-12-20 |
| A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (NCT03760666) | Clear Creek Bio, Inc. | 2018-12-20 |
| Study of ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma (NCT03802955) | Adagene (Suzhou) Limited | 2018-12-20 |
| Safety and Pharmacokinetics Study of CPL500036 Compound in Healthy Volunteers (NCT03873324) | Celon Pharma SA | 2018-12-20 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects. (NCT04084197) | Hanmi Pharmaceutical Company Limited | 2018-12-19 |
| A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal Function (NCT05469100) | Eli Lilly and Company | 2018-12-19 |
| Study to Evaluate the Tolerance and Pharmacokinetics of Suramin Sodium (NCT03804749) | First Affiliated Hospital of Zhejiang University | 2018-12-19 |
| Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects (NCT03980080) | OSE Immunotherapeutics | 2018-12-19 |
| Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets (NCT03740217) | Calliditas Therapeutics AB | 2018-12-19 |
| Pentamidine + Salvage Chemo for Relapsed/Refractory Classical Hodgkin Lymphoma (NCT03730363) | Reinhold Munker | 2018-12-19 |
| A Study of XY0206 in Subjects With Advanced or Metastatic Solid Tumours (NCT03658070) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2018-12-19 |
| Clinical Study of ICP-192 in Solid Tumors Patients (NCT03758664) | Beijing InnoCare Pharma Tech Co., Ltd. | 2018-12-19 |
| TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101) (NCT03247309) | Immatics US, Inc. | 2018-12-19 |
| An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen) (NCT03675126) | Sarepta Therapeutics, Inc. | 2018-12-19 |
| Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus (NCT03618056) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-12-19 |
| Study Comparing Two VAY736 Drug Products in Patients With Rheumatoid Arthritis (NCT03574545) | Novartis Pharmaceuticals | 2018-12-19 |
| A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors (NCT03775850) | Evelo Biosciences, Inc. | 2018-12-19 |
| Feasibility of Individualized Therapy for Recurrent Glioblastoma (NCT03681028) | Jennifer Clarke | 2018-12-19 |
| Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer (NCT03724747) | Bayer | 2018-12-18 |
| Intratumoral/Intralesional Administration of MK-4621/JetPEI™ With or Without Pembrolizumab in Participants With Advanced/Metastatic or Recurrent Solid Tumors (MK-4621-002) (NCT03739138) | Merck Sharp & Dohme LLC | 2018-12-18 |
| Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF (NCT03604315) | M.D. Anderson Cancer Center | 2018-12-18 |
| A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR206 in Healthy Volunteers (NCT03792308) | Spero Therapeutics | 2018-12-18 |
| Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (NCT03707938) | M.D. Anderson Cancer Center | 2018-12-18 |
| A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid Tumors (NCT03844438) | Luye Pharma Group Ltd. | 2018-12-18 |
| Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers (NCT05204121) | Viriom | 2018-12-18 |
| KN046 in Subjects With Advanced Solid Tumors and Lymphoma (NCT03733951) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2018-12-18 |
| A Study of the Safety, Tolerability, and Pharmacokinetics of SPR720 in Healthy Volunteers (NCT03796910) | Spero Therapeutics | 2018-12-18 |